Peak Bio, Inc.
PKBO · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $5 | $0 |
| - Cash | $0 | $0 | $1 | $0 |
| + Debt | $0 | $0 | $7 | $12 |
| Enterprise Value | $0 | $0 | $12 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | $3 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | $2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.007 | -0.006 | 0.06 | -0.09 |
| % Growth | -11.3% | -110.3% | 167% | – |
| Operating Cash Flow | – | – | -$2 | -$1 |
| Capital Expenditures | – | – | $0 | $0 |
| Free Cash Flow | – | – | -$2 | -$1 |